Apolipoproteins could be better predictor of heart attack than cholesterol

December 13, 2001

N.B. Please note that if you are outside North America the embargo for Lancet Press Material is 0001 hours UK Time Thursday 14th December 2001.

Measurement of lipid components called apolipoproteins could be a better indicator of heart-attack risk than conventional cholesterol assessment, conclude authors of a study in this week's issue of THE LANCET.

Hypercholesterolaemia, especially high concentrations of LDL-cholesterol, is one of the strongest risk factors for atherosclerotic cardiovascular disease. Recent studies have suggested that apolipoprotein B (apoB) and apolipoprotein A-I (apoA-I) might be better predictors of acute heart attack (myocardial infarction) than total cholesterol and LDL-cholesterol. Goran Walldius from AstraZeneca and the Karolinska Institute, Stockholm, Sweden, and colleagues investigated whether apoB and apoA-I were predictors of heart-attack risk. They also aimed to establish whether apoB and apoA-I could add further information about the risk of fatal heart attack to that obtained with total cholesterol, triglycerides, and LDL-cholesterol.

Around 175,000 Swedish people were studied, mainly from screening programmes. Concentrations of apoB, apoA-I, total cholesterol, and triglycerides were measured; the ratio for apoB/apoA-I and concentrations of LDL-cholesterol and HDL-cholesterol were calculated.

Average follow-up occurred at five and a half years after initial blood testing. 864 men and 359 women died from heart attack during the follow-up period. Total cholesterol, triglycerides, apoB and a high apoB/apoA-I ratio were strongly and positively related to increased risk of fatal heart attack in both men and women. Higher concentrations of ApoA-I had a protective effect; apoB was a stronger predictor of risk than LDL-cholesterol in both sexes.

Goran Walldius comments: "Although LDL-cholesterol and HDL-cholesterol are known risk factors, we suggest that apoB, apoB/apoA-I, and apoA-I should also be regarded as highly predictive in evaluation of cardiac risk. Although increased throughout the range of values of LDL-cholesterol, apoB and apoA-I might be of greatest value in diagnosis and treatment in men and women who have common lipid abnormalities, but have normal or low concentrations of LDL-cholesterol."

In an accompanying Commentary (p 2012), Gerald Berenson from Tulan University Health Sciences Centre, New Orleans, USA, cautions: "Before apo B and apo A-I can be used in routine clinical practice, assay methods need to be standardised and threshold and target values for diagnosis and treatment need to be agreed..."Quality control and assurance for apolipoprotein measurements, unlike those for measurements of cholesterol and triglycerides, are not applied in most commercial laboratories. This lack must be rectified before any specific clinical recommendations can be made."
-end-


Lancet

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.